Gts Securities LLC Rhythm Pharmaceuticals, Inc. Call Options Transaction History

Gts Securities LLC

  • $46.5 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$35.41 - $44.37 $152,262 - $190,791
-4,300 Reduced 38.39%
6,900 $283,000
Q1 2024

May 15, 2024
BUY
$39.12 - $52.44 $242,543 - $325,128
6,200 Added 124.0%
11,200 $485,000
Q4 2023

Feb 14, 2024
SELL
$21.39 - $49.64 $387,159 - $898,484
-18,100 Reduced 78.35%
5,000 $229,000
Q3 2023

Nov 15, 2023
BUY
$15.81 - $27.8 $365,211 - $642,180
23,100 New
23,100 $529,000

Others Institutions Holding RYTM

# of Institutions
178
Shares Held
69.1M
Call Options Held
467K
Put Options Held
224K
View Full List

About RHYTHM PHARMACEUTICALS, INC.

RYTM Quotes by TradingView
  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $2.84B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email